Skip to main content

FDx Advisors, Inc.

SEC CIK
0001566601
Latest filing
Aug 4, 2026

ARWR holding history

Arrowhead Pharmaceuticals, Inc. in every 13F filed by FDx Advisors, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARWR overviewAll 13F holders of ARWRFull Q2 2026 holdings

Shares (Q2 2026)
2,494
Value
$203.0K
% of portfolio
0.1%
Quarters held
2
Since Q2 2021
Holdings of ARWR by FDx Advisors, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,494$203.0K0.1%+2,494NewHolders
Q3 20210$00.0%−2,498−100.0%Sold outHolders
Q2 20212,498$207.0K<0.1%+2,498NewHolders